Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Clinical molecular imaging with positron emission tomography.

Saleem A, Charnley N, Price P.

Eur J Cancer. 2006 Aug;42(12):1720-7. Epub 2006 Jun 22. Review.

PMID:
16797972
3.

Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.

Francis DL, Visvikis D, Costa DC, Croasdale I, Arulampalam TH, Luthra SK, Taylor I, Ell PJ.

Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):928. Epub 2004 Mar 18. No abstract available.

PMID:
15034675
4.

Non-[18F]FDG PET in clinical oncology.

Groves AM, Win T, Haim SB, Ell PJ.

Lancet Oncol. 2007 Sep;8(9):822-30. Review.

PMID:
17765191
5.

Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.

Mankoff DA, Eary JF, Link JM, Muzi M, Rajendran JG, Spence AM, Krohn KA.

Clin Cancer Res. 2007 Jun 15;13(12):3460-9. Review.

6.

PET-CT imaging in pediatric oncology.

McCarville MB.

Cancer Imaging. 2009 Jun 29;9:35-43. doi: 10.1102/1470-7330.2009.0008. Review.

7.

Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.

Cintolo JA, Tchou J, Pryma DA.

Breast Cancer Res Treat. 2013 Apr;138(2):331-46. doi: 10.1007/s10549-013-2451-z. Epub 2013 Mar 16. Review.

PMID:
23504108
8.

[Oncology PET imaging].

Inubushi M.

Igaku Butsuri. 2014;34(1):3-9. Review. Japanese.

PMID:
25199271
9.

Can PET imaging facilitate optimization of cancer therapies?

Kramer-Marek G, Capala J.

Curr Pharm Des. 2012;18(18):2657-69. Review.

PMID:
22512443
10.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
11.

18F-fluorodeoxyglucose PET/CT in cancer imaging.

Kayani I, Groves AM.

Clin Med (Lond). 2006 May-Jun;6(3):240-4. Review. No abstract available.

PMID:
16826854
12.

Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases.

Pantaleo MA, Nannini M, Lopci E, Castellucci P, Maleddu A, Lodi F, Nanni C, Allegri V, Astorino M, Brandi G, Di Battista M, Boschi S, Fanti S, Biasco G.

Int J Oncol. 2008 Sep;33(3):443-52.

PMID:
18695872
13.

Monitoring predominantly cytostatic treatment response with 18F-FDG PET.

Contractor KB, Aboagye EO.

J Nucl Med. 2009 May;50 Suppl 1:97S-105S. doi: 10.2967/jnumed.108.057273. Review.

14.

[Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].

Bourguet P, Brusco S, Corone C, Devillers A, Foehrenbach H, Lumbroso JD, Maszelin P, Montravers F, Moretti JL, Rain JD, Talbot JN, Carretier J, Leichtnam-Dugarin L, Delavigne V, Philip T, Fervers B; Fédération nationale des centres de lutte contre le cancer (FNCLCC); Standards, Options: Recommendations; SFBMN; Ligue nationale contre le cancer; Fédération hospitalière de France; Fédération nationale de cancérologie des Centres hospitaliers régionaux et universitaires; Fédération française de cancérologie.

Bull Cancer. 2005 Jul;92(7):723-32. French.

15.

Positron emission tomography for modeling pathophysiological processes in vivo.

Hendrikse NH, Luurtsema G, van der Veldt AA, Lubberink M.

Curr Opin Drug Discov Devel. 2008 Sep;11(5):717-25. Review.

PMID:
18729023
16.

Cancer drug development using glucose metabolism radiopharmaceuticals.

Sun YY, Chen Y.

Curr Pharm Des. 2009;15(9):983-7.

PMID:
19275662
17.

Positron emission tomography imaging of tumor response after photodynamic therapy.

Berard V, Lecomte R, van Lier JE.

J Environ Pathol Toxicol Oncol. 2006;25(1-2):239-49. Review.

PMID:
16566721
18.

Positron emission tomography: clinical applications in oncology. Part 1.

Kumar R, Nadig MR, Chauhan A.

Expert Rev Anticancer Ther. 2005 Dec;5(6):1079-94. Review.

PMID:
16336099
19.
20.

Are we ready for dual-time point FDG PET imaging?

Lee ST, Scott AM.

J Med Imaging Radiat Oncol. 2011 Aug;55(4):351-2. doi: 10.1111/j.1754-9485.2011.02296.x. No abstract available.

PMID:
21843168

Supplemental Content

Support Center